Literature DB >> 34312266

Psychiatric Medication Users by Age and Sex in the United States, 1999-2018.

Michael E Johansen1.   

Abstract

PURPOSE: This study aimed to determine the rates of psychiatric medication users in the United States between 1999 to 2018 for different medication categories by age and sex.
METHODS: The 1999 to 2002, 2006 to 2009, and 2015 to 2018 Medical Expenditure Panel Surveys (MEPS) were used for the analysis. All individuals with a valid age were included. Any antidepressant, benzodiazepine, attention deficit hyperactivity disease (ADHD) medication, antipsychotics, and mood stabilizer report use was defined as a medication user. Separate multivariable logistic regression predicted medication users by age with restricted cubic splines by sex, medication category, and year category (1999 to 2002, 2006 to 2009, and 2015 to 2018). In addition, the rate of prescribing to males and females at different ages was determined for medication categories.
RESULTS: Rates of any psychiatric medication users increased during the study period. Females had higher rates of medication users around 20 years of age. Rates of antidepressant users increased over time and were higher for females after earlier adolescence. Rates of benzodiazepine users were higher for females, increased after 1999 to 2002, and had consistent patterns of use over time. Antipsychotic and mood stabilizer user rates were lower than other categories. Adolescent antipsychotic users markedly decreased between 2006 to 2009 and 2015 to 2018. Rates of ADHD medication users increased over time, particularly among younger adults between 25 and 50 years of age.
CONCLUSION: The rates of individuals reporting the use of any psychiatric medications increased over the last few decades. Rates and patterns of medication users have large variations by medication category, age, and sex, but these patterns of use were stable for most medication categories. © Copyright 2021 by the American Board of Family Medicine.

Entities:  

Keywords:  Attention Deficit Disorder With Hyperactivity; Benzodiazepines; Health Services Research; Logistic Regression; Mental Health Services; Primary Health Care; Psychiatry; Psychopharmacology; Psychotropic Drugs; Surveys and Questionnaires

Mesh:

Substances:

Year:  2021        PMID: 34312266     DOI: 10.3122/jabfm.2021.04.200596

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  1 in total

1.  The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records.

Authors:  Rebecca M Joseph; Ruth H Jack; Richard Morriss; Roger David Knaggs; Debbie Butler; Chris Hollis; Julia Hippisley-Cox; Carol Coupland
Journal:  BMC Med       Date:  2022-02-02       Impact factor: 8.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.